ערך בספרים למניה: Procaps (PROC)
Profit growth for Procaps Group S.A. (PROC) is constrained by compliance costs amid moderate operating leverage. The key book value metric reflects equity dynamics, where 0.00 determines the latest valuation figure. This underscores the significance of the Softgel ecosystem for global pharmaceutical leaders. The company's high-tech cGMP plants located in the US, Brazil, and Colombia ensure supply stability.
%20%D7%A2%D7%A8%D7%9A%20%D7%97%D7%A9%D7%91%D7%95%D7%A0%D7%90%D7%99%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94&width=1200&height=400&colorIndex=0&v=mvouo2ve.rkk-7albim8&start=20220704&end=20261026&filename=GURU_Markets_-_PROC_-_Procaps-Group-S.A._-_Accounting-Value-per-Share "PROC (procapsgroup.com) היסטוריית נכסים נקיים למניה בודדת מ-04.07.2022 עד 16.02.2025 | 👁️GURU.Markets👁️")
procapsgroup.com - פילוחים אנליטיים ומדדי מפתח (PROC)
Book value per share measures the portion of equity attributable to a single security, which determines the intrinsic asset value of the business. The BVPS trend depends directly on quarterly reporting, reflecting the efficiency of asset capitalization at Procaps Group S.A. (PROC) during the implementation of ESG environmental standards and the modernization of pharmaceutical production treatment systems.